Shingrix Approved to Prevent Shingles in Immunocompromised Adults
Previously, the vaccine was only approved for adults 50 years of age and older.
Infectious Disease
SARS-CoV-2 May Be Linked to Immune-Mediated Myopathy
In this case-control autopsy series, study researchers evaluated skeletal muscle and myocardial inflammations in patients with severe COVID-19 who died.
Dalvance Approved for Children With Acute Bacterial Skin/Skin Structure Infections
Dalvance is a second-generation, semi-synthetic lipoglycopeptide.
Conjunctival Swabs Not Sensitive Enough to Detect COVID-19
The presence of coronavirus RNA in conjunctiva does highlight tears as a possible mode of disease transmission, the report suggests.
COVID-19 Is Associated With Low Testosterone in Men
Study reveals that almost 90% of men have hypogonadism at the time of hospital admission for COVID-19.
Case Study: Herpes Zoster in Patients With MS Treated With Dimethyl Fumarate
This case study examines 2 patients with relapsing remitting multiple sclerosis, under dimethyl fumarate treatment, who developed severe herpes zoster infection.
Evidence Lacking for Tocilizumab Use in Dermatologic Conditions
The clinical dermatologic use of tocilizumab, its mechanisms of action, and adverse events is reviewed.
Effect of ART, OUD Intervention on Viral Suppression in People With HIV Who Inject Drugs
Investigators studied longer-term treatment with an integrated intervention with psychosocial counseling and supported referrals for antiretroviral therapy and substance use treatment.
Kimyrsa Now Available for Acute Bacterial Skin/Skin Structure Infections
Kimyrsa is a single-dose, long-acting lipoglycopeptide antibiotic.
HIV Pre-Exposure Prophylaxis Does Not Increase Risky Sexual Behaviors: A Study in West Africa
Investigators assessed the use of HIV pre-exposure prophylaxis and its impact on behaviors and the incidence of sexually transmitted infections in West African men who have sex with men.
- Loading...
Loading...
Next post in General Dermatology
Loading... 
Loading...